Skip to search form
Skip to main content
>
Semantic Scholar
Semantic Scholar's Logo
Search
Sign In
Create Free Account
You are currently offline. Some features of the site may not work correctly.
cyclophosphamide/fluorouracil/fluoxymesterone/methotrexate
Known as:
CMFH
, CTX/5-FU/FXM/MTX
National Institutes of Health
Create Alert
Related topics
Related topics
4 relations
Cyclophosphamide
Fluorouracil
Fluoxymesterone
Methotrexate
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
A prospective evaluation of chemohormonal therapy remission maintenance in advanced breast cancer
D. Tormey
,
R. Gelman
,
+4 authors
G. Falkson
Breast Cancer Research and Treatment
2005
Corpus ID: 2283403
SummaryFrom October 1973 to October 1977 the ECOG prospectively evaluated cyclophosphamide, methotrexate, and fluorouracil (CMF…
Expand
1993
1993
Nuclear DNA content of isolated crypts of background colonic mucosa from patients with familial adenomatous polyposis and sporadic colorectal cancer.
S. Nakamura
,
I. Kino
,
S. Baba
Gut
1993
Corpus ID: 206953367
The DNA content of the upper one third of the crypt epithelium was compared with that of the lower two thirds in the background…
Expand
1986
1986
A clinical trial of homoharringtonine in the treatment of advanced breast cancer.
Zhao Tp
,
Ding Gx
,
Gao Hy
,
Shen Zz
,
Li Ky
1986
Corpus ID: 74278416
Abstract Two combination chemotherapy protocols, CMF (cyclophosphamide, methotrexate, fluorouracil) and CMFH (CMF plus…
Expand
1986
1986
A clinical trial of homoharringtonine in the treatment of advanced breast cancer.
T. Zhao
,
Genxiong Ding
,
Haoyong Gao
,
Z. Shen
,
Katherine Li Yueyun
Tumori
1986
Corpus ID: 33359267
Two combination chemotherapy protocols, CMF (cyclophosphamide, methotrexate, fluorouracil) and CMFH (CMF plus homoharringtonine…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
,
Terms of Service
, and
Dataset License
ACCEPT & CONTINUE